You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (14)

Journals (0)

1-10 of 14 results for Actavis

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Ucb,Inc. V. Actavis Lab'ys Ut,Inc.

Retricted access

Case report

First published 2023-06

Ucb,Inc. V. Actavis Lab'ys Ut,Inc.

Christopher M. Holman

Biotechnology Law Report

Select article: Tris Pharma,Inc. v. Actavis Lab'ys FL,Inc.

Retricted access

Research article

First published 2022-10

Tris Pharma,Inc. v. Actavis Lab'ys FL,Inc.

Christopher M. Holman

Biotechnology Law Report

Select article: The Fate of FTC v. Actavis,Inc . in the Biosimilar Context—Does and Should the FTC v. Actavis Decision Apply to Reverse Patent Settlements Between Brand Drug and Biosimilar Manufacturers?

Retricted access

Research article

First published 2022-08

The Fate of FTC v. Actavis,Inc . in the Biosimilar Context—Does and Should the FTC v. Actavis Decision Apply to Reverse Patent Settlements Between Brand Drug and Biosimilar Manufacturers?

Nicola Gabrielle Ho

Biotechnology Law Report

Select article: Orexo AB v. Actavis Elizabeth LLC United States Court of Appeals of the Federal Circuit,2018 903 F.3d 1265

Retricted access

Research article

First published 2018-12

Orexo AB v. Actavis Elizabeth LLC United States Court of Appeals of the Federal Circuit,2018 903 F.3d 1265

Biotechnology Law Report

Select article: Photocure ASA v. Kappos et al and Actavis Elizabeth LLC v. USFDA : The Meaning of ‘Active Ingredient’ in the Hatch–Waxman Act

Retricted access

Research article

First published 2011-1

Photocure ASA v. Kappos et al and Actavis Elizabeth LLC v. USFDA : The Meaning of ‘Active Ingredient’ in the Hatch–Waxman Act

Frederick H. Rein, Joseph B. Crystal

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Select article: Endo Pharm. Inc. v. Actavis LLC United States Court of Appeals of the Federal Circuit,2019 922 F.3d 1365

Retricted access

Research article

First published 2019-08

Endo Pharm. Inc. v. Actavis LLC United States Court of Appeals of the Federal Circuit,2019 922 F.3d 1365

Biotechnology Law Report

Select article: Brief of the Washington Legal Foundation in Support of Respondents in Federal Trade Commission v. Actavis,Inc.,et al. (Supreme Court of the United States)

Retricted access

Case report

First published 2013-06

Brief of the Washington Legal Foundation in Support of Respondents in Federal Trade Commission v. Actavis,Inc.,et al. (Supreme Court of the United States)

Biotechnology Law Report

Select article: HZNP Medicines LLC v. Actavis Labs. UT,Inc. United States Court of Appeals of the Federal Circuit,2019 940 F.3d 680

Retricted access

Research article

First published 2019-12

HZNP Medicines LLC v. Actavis Labs. UT,Inc. United States Court of Appeals of the Federal Circuit,2019 940 F.3d 680

Biotechnology Law Report

Select article: Nalpropion Pharm.,Inc. v. Actavis Labs. FL,Inc. United States Court of Appeals of the Federal Circuit,2019 No. 2018-1221,2019 WL 3819335

Retricted access

Research article

First published 2019-10

Nalpropion Pharm.,Inc. v. Actavis Labs. FL,Inc. United States Court of Appeals of the Federal Circuit,2019 No. 2018-1221,2019 WL 3819335

Biotechnology Law Report

Select article: Pay for Delay Agreements: Antitrust Watch Intensifies

Retricted access

Research article

First published 2018-7

Pay for Delay Agreements: Antitrust Watch Intensifies

Twinkle Chawla, Ruchi Verma

Journal of National Law University Delhi

1
2
10 / page

Article type

Publication date

Subjects

Access